(Q35006534)

5 August 2017

1 reference

title

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? (English)

1 reference

5 August 2017

0 references

1 reference

1

George Perry

1 reference

5 August 2017

4

Xiongwei Zhu

1 reference

5 August 2017

12

Mark A Smith

1 reference

5 August 2017

8

Craig S Atwood

1 reference

5 August 2017

3

Keisuke Hirai

1 reference

5 August 2017

10

Lawrence M Sayre

1 reference

5 August 2017

6

Jesús Avila

1 reference

5 August 2017

2

Akihiko Nunomura

1 reference

5 August 2017

9

Gjumrakch Aliev

1 reference

5 August 2017

Mar Pérez

5

1 reference

5 August 2017

Rudolph J Castellani

series ordinal

7

1 reference

5 August 2017

Atsushi Takeda

series ordinal

11

1 reference

5 August 2017

language of work or name

1 reference

1 December 2002

1 reference

Free Radical Biology and Medicine

5 August 2017

published in

1 reference

5 August 2017

volume

33

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1475-1479

1 reference

Protein oxidation in aging brain

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Levuglandin E2-protein adducts in human plasma and vasculature.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

A tombstone in Alzheimer's?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Early AGEing and Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Oxidative damage in Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Redox-active iron mediates amyloid-beta toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

1 reference

7 January 2021

Arson. Tracking the culprit in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

A suicide note from Alzheimer disease neurons?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Apoptosis and Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Oxidative damage to nucleic acids in human prion disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Lipoperoxidation is selectively involved in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

The mitochondrial common deletion in Parkinson's disease and related movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2901113-9

7 January 2021

10.1016/S0891-5849(02)01113-9

Identifiers

DOI

1 reference

5 August 2017

1 reference